HIGHLIGHTS
- who: Anja Reuter and colleagues from the South Africa Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa have published the research work: Implementing a Substance-Use Screening and Intervention Program for People Living with Rifampicin-Resistant Tuberculosis: Pragmatic Experience from Khayelitsha, South Africa, in the Journal: (JOURNAL) of 30/09/2020
- what: The authors aim to describe the results of this pilot program by describing SU screening, screening scores, and RR-TB treatment outcomes for persons screened for SU within 2 months of treatment initiation. This research fulfilled the exemption criteria . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.